evidencegaps
Primary study · included by 1 review

The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma.

Shen 2021 · Shen Dijian, Chen Qixun, Wu Jie, et al. · Journal of gastrointestinal oncology · 2021

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Shen 2021 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.